ASX:COHMedical Equipment
How Investors Are Reacting To Cochlear (ASX:COH) FDA Approval Of Its Rechargeable Osia 3 Processor
Cochlear Limited has received FDA clearance for its Osia 3 Sound Processor, the first fully rechargeable active bone conduction sound processor, offering up to 30 hours of battery life, broader fitting ranges, and expanded connectivity including Auracast broadcast audio.
Clinical research indicating high patient satisfaction and improved speech understanding, combined with backwards compatibility for existing Osia users, positions Osia 3 as a meaningful enhancement to Cochlear’s upgrade...
